TW240217B - - Google Patents

Info

Publication number: TW240217B
Authority: TW; Taiwan

Application number

TW082111006A

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-12-30

Filing date

1993-12-27

Publication date

1995-02-11

1992-12-30 Priority claimed from GB929227116A external-priority patent/GB9227116D0/en

1992-12-30 Priority claimed from GB929227125A external-priority patent/GB9227125D0/en

1993-12-27 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

1995-02-11 Application granted granted Critical

1995-02-11 Publication of TW240217B publication Critical patent/TW240217B/zh

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/04—Five-membered rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

TW082111006A 1992-12-30 1993-12-27 TW240217B (zh)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB929227116A GB9227116D0 (en)	1992-12-30	1992-12-30	Chemical compounds
GB929227125A GB9227125D0 (en)	1992-12-30	1992-12-30	Chemical compounds

Publications (1)

Publication Number	Publication Date
TW240217B true TW240217B (zh)	1995-02-11

Family

ID=26302242

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW082111006A TW240217B (zh)	1992-12-30	1993-12-27

Country Status (5)

Country	Link
CN (1)	CN1094037A (zh)
AU (1)	AU5815594A (zh)
IL (1)	IL108218A0 (zh)
TW (1)	TW240217B (zh)
WO (1)	WO1994015920A1 (zh)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995015954A1 (en) *	1993-12-07	1995-06-15	Smithkline Beecham Plc	Heterocyclic biphenylylamides useful as 5ht1d antagonists
GB9507203D0 (en) *	1995-04-07	1995-05-31	Smithkline Beecham Plc	Novel compounds
FR2740134B1 (fr) *	1995-10-18	1998-01-09	Pf Medicament	Derives d'amines cycliques d'aryl-piperazines, leur preparation et les compositions pharmaceutiques les contenant
FR2744450A1 (fr) *	1996-02-02	1997-08-08	Pf Medicament	Nouvelles naphtylpiperazines derivees de cycloazanes substitues, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments
FR2744449B1 (fr) *	1996-02-02	1998-04-24	Pf Medicament	Nouvelles piperazines aromatiques derivees de cycloazanes substitues, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments
EP0946551A2 (en) *	1996-12-19	1999-10-06	Smithkline Beecham Plc	N-piperazin-1-ylphenyl-benzamide derivatives
ATE315033T1 (de)	1998-08-07	2006-02-15	Chiron Corp	Subtituierte isoxazole derivate als estrogen rezeptor modulatore
SE9904723D0 (sv) *	1999-12-22	1999-12-22	Carlsson A Research Ab	New modulators of dopamine neurotransmission II
PE20020506A1 (es)	2000-08-22	2002-07-09	Glaxo Group Ltd	Derivados de pirazol fusionados como inhibidores de la proteina cinasa
GB0124939D0 (en)	2001-10-17	2001-12-05	Glaxo Group Ltd	Chemical compounds
GB0124938D0 (en)	2001-10-17	2001-12-05	Glaxo Group Ltd	Chemical compounds
GB0124934D0 (en)	2001-10-17	2001-12-05	Glaxo Group Ltd	Chemical compounds
GB0124931D0 (en)	2001-10-17	2001-12-05	Glaxo Group Ltd	Chemical compounds
GB0124933D0 (en)	2001-10-17	2001-12-05	Glaxo Group Ltd	Chemical compounds
GB0124936D0 (en)	2001-10-17	2001-12-05	Glaxo Group Ltd	Chemical compounds
GB0124941D0 (en)	2001-10-17	2001-12-05	Glaxo Group Ltd	Chemical compounds
EP1864975B1 (en)	2002-02-12	2010-10-20	GlaxoSmithKline LLC	Nicotinamide derivates useful as P38 inhibitors
GB0209891D0 (en) *	2002-04-30	2002-06-05	Glaxo Group Ltd	Novel compounds
GB0217757D0 (en)	2002-07-31	2002-09-11	Glaxo Group Ltd	Novel compounds
GB0308185D0 (en)	2003-04-09	2003-05-14	Smithkline Beecham Corp	Novel compounds
GB0308201D0 (en)	2003-04-09	2003-05-14	Smithkline Beecham Corp	Novel compounds
GB0308186D0 (en)	2003-04-09	2003-05-14	Smithkline Beecham Corp	Novel compounds
GB0318814D0 (en)	2003-08-11	2003-09-10	Smithkline Beecham Corp	Novel compounds
JO3598B1 (ar)	2006-10-10	2020-07-05	Infinity Discovery Inc	الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
US7737149B2 (en)	2006-12-21	2010-06-15	Astrazeneca Ab	N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
PE20091838A1 (es)	2008-04-09	2009-12-18	Infinity Pharmaceuticals Inc	Inhibidores de amida hidrolasa de acido graso
US9034849B2 (en)	2010-02-03	2015-05-19	Infinity Pharmaceuticals, Inc.	Fatty acid amide hydrolase inhibitors
KR20130106410A (ko) *	2010-10-30	2013-09-27	루핀 리미티드	Crac 조절제인 옥사졸린과 이소옥사졸린 유도체
US20140179712A1 (en)	2012-12-21	2014-06-26	Astrazeneca Ab	Pharmaceutical formulation of n-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2h-pyrazol-3-yl]-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl]benzamide
US11498903B2 (en)	2017-08-17	2022-11-15	Bristol-Myers Squibb Company	2-(1,1′-biphenyl)-1H-benzodimidazole derivatives and related compounds as apelin and APJ agonists for treating cardiovascular diseases
WO2020183011A1 (en)	2019-03-14	2020-09-17	Institut Curie	Htr1d inhibitors and uses thereof in the treatment of cancer
KR20230107566A (ko) *	2020-10-08	2023-07-17	레우코스 바이오테크 에스. 엘.	세로토닌 1b 수용체 조절제로서 효력있고 선택적인 화합물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0533268B1 (en) *	1991-09-18	2001-08-16	Glaxo Group Limited	Benzanilide derivatives as 5-HT1D antagonists

1993
- 1993-12-27 TW TW082111006A patent/TW240217B/zh active
- 1993-12-28 AU AU58155/94A patent/AU5815594A/en not_active Abandoned
- 1993-12-28 WO PCT/EP1993/003708 patent/WO1994015920A1/en active Application Filing
- 1993-12-29 IL IL10821893A patent/IL108218A0/xx unknown
- 1993-12-29 CN CN93121518.8A patent/CN1094037A/zh active Pending

Also Published As

Publication number	Publication date
AU5815594A (en)	1994-08-15
IL108218A0 (en)	1994-04-12
WO1994015920A1 (en)	1994-07-21
CN1094037A (zh)	1994-10-26

Publication	Publication Date	Title
DK0634000T3 (zh)	1997-02-24
DK0598561T3 (zh)	1997-03-24
TW217476B (zh)	1993-12-11
TW240217B (zh)	1995-02-11
DK0551248T3 (zh)	1997-02-17
TW238295B (zh)	1995-01-11
DK0574087T3 (zh)	1997-01-20
TW256793B (zh)	1995-09-11
DK0596750T3 (zh)	1997-02-24
DK0632741T3 (zh)	1997-02-24
DK0576346T3 (zh)	1997-03-10
DK0571874T3 (zh)	1997-03-13
DK0574276T3 (zh)	1997-07-07
TW227558B (zh)	1994-08-01
DK0564197T3 (zh)	1997-03-24
DK0596569T3 (zh)	1997-03-17
TW275687B (zh)	1996-05-11
DK0599441T3 (zh)	1997-01-20
TW240288B (zh)	1995-02-11
DE9209779U1 (zh)	1992-09-17
AU632452B2 (zh)	1992-12-24
AU631518B2 (zh)	1992-11-26
BRPI9204323A2 (zh)	1994-05-10
IN176828B (zh)	1996-09-21
IN185205B (zh)	2000-12-02